Strontium chloride
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Strontium chloride is a metal halide that is FDA approved for the treatment of bone pain in patients with painful skeletal metastases.. Common adverse reactions include increased pain, flushing, fatigue.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
STRONTIUM CHLORIDE Sr-89 INJECTION, USP is indicated for the relief of bone pain in patients with painful skeletal metastases.
The presence of bone metastases should be confirmed prior to therapy.
Dosage
The recommended dose of Strontium-89 Chloride is 148 MBq, 4 mCi, administered by slow intravenous injection (1-2 minutes). Alternatively, a dose of 1.5 - 2.2 MBq/kg, 40-60 µCi/kg body weight may be used.
Repeated administrations of Strontium-89 Chloride should be based on an individual patient’s response to therapy, current symptoms, and hematologic status, and are generally not recommended at intervals of less than 90 days.
The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Strontium chloride in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Strontium chloride in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
- Safety and effectiveness in children below the age of 18 years have not been established.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Strontium chloride in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Strontium chloride in pediatric patients.
Contraindications
- None
Warnings
- Description
Precautions
- Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Strontium chloride in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Strontium chloride in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Strontium chloride in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Strontium chloride during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Strontium chloride with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Strontium chloride with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Strontium chloride with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Strontium chloride with respect to specific gender populations.
Race
There is no FDA guidance on the use of Strontium chloride with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Strontium chloride in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Strontium chloride in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Strontium chloride in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Strontium chloride in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Strontium chloride in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Strontium chloride in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Strontium chloride in the drug label.
Pharmacology
There is limited information regarding Strontium chloride Pharmacology in the drug label.
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Strontium chloride in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Strontium chloride in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Strontium chloride in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Strontium chloride in the drug label.
How Supplied
Storage
There is limited information regarding Strontium chloride Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Strontium chloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Strontium chloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Strontium chloride in the drug label.
Precautions with Alcohol
- Alcohol-Strontium chloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Strontium chloride |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Strontium chloride |Label Name=Strontium chloride11.png
}}
{{#subobject:
|Label Page=Strontium chloride |Label Name=Strontium chloride11.png
}}